Back in 2024, Formula 1 announced a new multi-year contract with Hot Wheels, The partnership kicked off with the release of a one-of-a-kind F1 car, before the full Hot Wheels range - featuring teams' ...

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies. The company is signing on to a collaboration and option agreement with Memo Therapeutics that could ...

CSL Limited trades at a decade-low P/E, despite ongoing revenue and profit growth, presenting significant upside potential. CSL's vaccine business volatility and slow margin recovery, especially at ...

At first glance, F1 wheel covers look like a step backward. In reality, they solve two massive problems at once. They clean up dirty air and stop teams spending millions chasing tiny aero gains.

The Sphere's Cadillac F1 ad in Las Vegas, Nov. 2025 (left); Isack Hadjar's Red Bull at Abu Dhabi post-season testing, Dec. 2025 (right). Aaron M. Sprecher/Getty Images; Nicolas Economou/NurPhoto via ...

The College Swimming League (CSL), a revolutionary sports enterprise, today unveiled its plans to fundamentally reimagine college swimming. Founded by Robert Kent and Kyle Sockwell, with support from ...

Forget one of one: this particular BMW 3.0 CSL is, quite literally, the very first M race car, and it’s up for sale for presumably many dollars. The very first official BMW M project was the 3.0 CSL.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company announced in August ...

CSL Ltd., the world’s second-biggest maker of flu shots, forecast a US vaccination rebound as health groups counter misinformation and rising illness rates revive concern about prevention. A recovery ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Lando Norris may have taken the checkered flag at F1 ...

Alongside the U.S. government’s overhaul of the federal vaccine infrastructure, influenza vaccination rates in the country have plummeted below the expectations of a key player in the space. That ...

SYDNEY, Oct 28 (Reuters) - Australian biotech CSL (CSL.AX), opens new tab has cut its profit outlook and delayed plans to spin off its vaccine division, blaming an unprecedented fall in U.S. flu ...